Amanpreet Singh Gill

Capital equipment (CT and MRI): Guide a dedicated investment of $2 billion over three years for radiology equipment to improve access to modern medical imaging equipment. Streamline the process for equipment installation and reduce the substantial associated labour costs. Clinical decision support: Support the national integration of Clinical Decision Support (CDS) systems into electronic medical records (EMRs) to ensure that patients receive the right test at the right time. Health human resources: Develop a strategy to recruit and retain radiologists, medical radiation technologists, and sonographers as part of a national approach to health human resources to reduce backlogs and improve health services. Federal Budget - investment in First Nations communities for medical imaging equipment and access to radiologists to improve care for population Artificial Intelligence: Demonstrate leadership in AI by providing financial support for the Health Artificial Intelligence Validation Network (HAIVN) to improve the evaluation and regulation of AI in Canada as part of Health Canada’s Medical Devices Directorate regulatory process, for the purpose of improved healthcare, economic development and innovation in Canada.

Tobacco and Vaping Products Act with regards to the classification of tobacco and vaping products, product regulation, packaging and labeling Schedule 1 of the Excise Act 2001 (Sections 42, 43.1 and 58.2, subsections 216(2) and (3), and section 240) under the Rate of Duty on Tobacco Products Excise Act, 2001 -with regard to tobacco and vaping duties, stamps or collection. Customs Act/Customs Tariff - with regard to customs duties on tobacco and vaping products. Any new legislative or regulatory proposals or policies relating to tobacco and/or vaping including taxation, product regulation, flavouring, packaging and labeling requirements and contraband. Any new legislative or regulatory proposals or policies relating to the recycling of tobacco-related and vaping products. Any new legislative or regulatory proposals, or policies, relating to non-combustible, smoke-free, nicotine products Any new legislative or regulatory proposals, or policies, relating to harm reduction as it pertains to combustible tobacco products.